Pfizer

{
  "main_header": {
    "sid": 970356,
    "name": "Pfizer",
    "stock_name": "Pfizer",
    "full_name": "Pfizer Ltd.",
    "name_url": "stocks-analysis/pfizer",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,822.80",
    "chg": 23.75,
    "chgp": "0.49%",
    "dir": 1,
    "prev_price": "4,799.05",
    "mcapval": "22,022.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500680,
    "symbol": "PFIZER",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE182A01018",
    "curr_date": "Jul 31, 03:30 PM",
    "curr_time": "14:43 PM",
    "last_traded_at": "Jul 31, 03:30 PM IST",
    "bse_nse_vol": "27.42 k",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pfizer-970356-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Pfizer Ltd Gains 4.44%: 2 Key Factors Driving the Weekly Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-gains-444-2-key-factors-driving-the-weekly-rally-4131571",
        "imagepath": "",
        "date": "2026-08-01 14:03:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens week at Rs.4,690.15, up 1.57%</p>\n                    <p><strong>28 Jul:</strong> Q1 FY27 results reveal strong profit growth, stock rises 0.33%</p>\n                    <p><strong>29 Jul:</strong> Quarterly turnaround confirmed, stock gains 1.04%</p>\n                    <p><strong>30 Jul:</strong> Continued positive momentum, stock up 0.93%</p>\n                    <p><strong>31 Jul:</strong> Week closes at Rs.4,822.80, up 0.49%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.4,690.15</div></div>\n                    <div class..."
      },
      {
        "title": "Are Pfizer Ltd. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-pfizer-ltd-latest-results-good-or-bad-4127142",
        "imagepath": "",
        "date": "2026-07-29 19:19:37",
        "description": "Pfizer Ltd.'s latest financial results for Q1 FY27 reveal a company demonstrating operational strength amidst a competitive landscape. The net sales reached ₹653.17 crores, reflecting a sequential growth of 3.80% and an annual increase of 8.31%. This growth trajectory indicates consistent demand across its portfolio of specialized medicines, which spans 15 therapeutic areas. The company achieved a net profit of ₹204.47 crores, marking a 2.33% increase from the previous quarter and a 6.63% rise year-on-year.\n\nA notable highlight from the results is the operating margin, which reached 37.90%, the highest recorded in the company's history. This margin expansion illustrates effective cost management and operational efficiency, even as employee costs rose. The return on equity stood at a robust 18.05%, indicating strong capital efficiency.\n\nDespite these positive operational metrics, Pfizer faces challenges rega..."
      },
      {
        "title": "Pfizer Ltd. Reports Strong Quarterly Financial Turnaround Amid Positive Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-reports-strong-quarterly-financial-turnaround-amid-positive-market-momentum-4124925",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PfizerLtd_fintrenddot_4124925.png",
        "date": "2026-07-29 08:00:22",
        "description": "Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to positive, driven by record-breaking revenue and profitability metrics, signalling a potential turnaround despite a challenging broader market environment."
      },
      {
        "title": "Pfizer Ltd. Q1 FY27: Strong Profit Growth Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/pfizer-ltd-q1-fy27-strong-profit-growth-masks-valuation-concerns-4124696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Pfizer_quaterlyResult_4124696.png",
        "date": "2026-07-28 20:01:55",
        "description": "Pfizer Ltd. reported a net profit of ₹204.47 crores for Q1 FY27 (quarter ended June 2026), marking a sequential increase of 2.33% from ₹199.82 crores in Q4 FY26 and a year-on-year growth of 6.63% from ₹191.75 crores in Q1 FY26. The pharmaceutical major, with a market capitalisation of ₹21,584 crores, demonstrated resilient operational performance with its highest-ever quarterly revenue and operating profit margins, though investors remain cautious as the stock trades 19.95% below its 52-week high of ₹5,878.55."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-4122400",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PfizerLtd_mojoScore_4122400.png",
        "date": "2026-07-27 10:10:55",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-amid-mixed-market-signals-4114476",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PfizerLtd_technicaldot_4114476.png",
        "date": "2026-07-22 08:03:09",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.35%, the stock’s recent downgrade from Hold to Sell by MarketsMOJO underscores growing caution among analysts as technical indicators reveal a transition from bearish to mildly bearish trends."
      },
      {
        "title": "When is the next results date for Pfizer Ltd.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-pfizer-ltd-4114184",
        "imagepath": "",
        "date": "2026-07-21 23:17:11",
        "description": "The next results date for Pfizer Ltd. is scheduled for 28 July 2026...."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-to-bearish-amid-market-pressure-4108522",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PfizerLtd_technicaldot_4108522.png",
        "date": "2026-07-20 08:03:21",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This change is underscored by deteriorating technical indicators including MACD, moving averages, and Bollinger Bands, signalling increased selling pressure and subdued investor sentiment as the stock price declined by 2.64% on 20 Jul 2026."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-4104940",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PfizerLtd_mojoScore_4104940.png",
        "date": "2026-07-16 10:10:52",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 386,
    "sid": "970356",
    "stock_news_url": "https://www.marketsmojo.com/news/pfizer-970356"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "29-Jul-2026",
      "details": "Pursuant to Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we submit herewith the consolidated Scrutinizers Report of the votes cast through remote e-voting and electronic polling process conducted during the 75th Annual General Meeting of the Company held on Tuesday July 28 2026 at 3.00 p.m. IST.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "28-Jul-2026",
      "details": "Pursuant to Regulation 30 of SEBI LODR Regulations 2015 please find enclosed proceedings of the 75th Annual General Meeting of the Company held on July 28 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30 2026.",
      "datetime": "28-Jul-2026",
      "details": "Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the Unaudited Financial Results of the Company for the quarter ended June 30 2026 which were approved by the Board of Directors of the Company at their Meeting held today i.e. July 28 2026 that commenced at 11.30 a.m. and concluded at 1.35 p.m.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Pfizer Ltd. has declared <strong>750%</strong> dividend, ex-date: 17 Jul 26",
          "dt": "2026-07-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pfizer Ltd Gains 4.44%: 2 Key Factors Driving the Weekly Rally

2026-08-01 14:03:31

Key Events This Week

27 Jul: Stock opens week at Rs.4,690.15, up 1.57%

28 Jul: Q1 FY27 results reveal strong profit growth, stock rises 0.33%

29 Jul: Quarterly turnaround confirmed, stock gains 1.04%

30 Jul: Continued positive momentum, stock up 0.93%

31 Jul: Week closes at Rs.4,822.80, up 0.49%

Week Open

Rs.4,690.15

Read full news article

Are Pfizer Ltd. latest results good or bad?

2026-07-29 19:19:37

Pfizer Ltd.'s latest financial results for Q1 FY27 reveal a company demonstrating operational strength amidst a competitive landscape. The net sales reached ₹653.17 crores, reflecting a sequential growth of 3.80% and an annual increase of 8.31%. This growth trajectory indicates consistent demand across its portfolio of specialized medicines, which spans 15 therapeutic areas. The company achieved a net profit of ₹204.47 crores, marking a 2.33% increase from the previous quarter and a 6.63% rise year-on-year. A notable highlight from the results is the operating margin, which reached 37.90%, the highest recorded in the company's history. This margin expansion illustrates effective cost management and operational efficiency, even as employee costs rose. The return on equity stood at a robust 18.05%, indicating strong capital efficiency. Despite these positive operational metrics, Pfizer faces challenges rega...

Read full news article

Pfizer Ltd. Reports Strong Quarterly Financial Turnaround Amid Positive Market Momentum

2026-07-29 08:00:22

Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to positive, driven by record-breaking revenue and profitability metrics, signalling a potential turnaround despite a challenging broader market environment.

Read full news article

Pfizer Ltd. Q1 FY27: Strong Profit Growth Masks Valuation Concerns

2026-07-28 20:01:55

Pfizer Ltd. reported a net profit of ₹204.47 crores for Q1 FY27 (quarter ended June 2026), marking a sequential increase of 2.33% from ₹199.82 crores in Q4 FY26 and a year-on-year growth of 6.63% from ₹191.75 crores in Q1 FY26. The pharmaceutical major, with a market capitalisation of ₹21,584 crores, demonstrated resilient operational performance with its highest-ever quarterly revenue and operating profit margins, though investors remain cautious as the stock trades 19.95% below its 52-week high of ₹5,878.55.

Read full news article

Pfizer Ltd. is Rated Sell

2026-07-27 10:10:55

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pfizer Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-07-22 08:03:09

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.35%, the stock’s recent downgrade from Hold to Sell by MarketsMOJO underscores growing caution among analysts as technical indicators reveal a transition from bearish to mildly bearish trends.

Read full news article

When is the next results date for Pfizer Ltd.?

2026-07-21 23:17:11

The next results date for Pfizer Ltd. is scheduled for 28 July 2026....

Read full news article

Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Market Pressure

2026-07-20 08:03:21

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This change is underscored by deteriorating technical indicators including MACD, moving averages, and Bollinger Bands, signalling increased selling pressure and subdued investor sentiment as the stock price declined by 2.64% on 20 Jul 2026.

Read full news article

Pfizer Ltd. is Rated Sell by MarketsMOJO

2026-07-16 10:10:52

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News